Natus Medical Incorporated Sustainability Profile
Natus Medical Incorporated, commonly referred to as Natus, is a leading provider of medical devices and services headquartered in the United States. Founded in 1989, the company has established a strong presence in the neurodiagnostic, newborn care, and hearing screening sectors, serving healthcare professionals across North America and globally. Natus is renowned for its innovative products, including advanced neurodiagnostic systems, neonatal monitoring solutions, and audiology equipment, which are designed to enhance patient care and improve clinical outcomes. The company’s commitment to quality and technological advancement has positioned it as a trusted partner in the medical community. With a focus on delivering exceptional value, Natus has achieved significant milestones, including numerous industry awards and recognitions, solidifying its status as a key player in the medical technology landscape.
DitchCarbon Score
How does Natus Medical Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Natus Medical Incorporated's score of 27 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Natus Medical Incorporated's reported carbon emissions
In 2023, Natus Medical Incorporated reported total carbon emissions of approximately 25,188,000 kg CO2e. This figure encompasses all scopes of emissions, although specific breakdowns for Scope 1, Scope 2, and Scope 3 emissions were not disclosed for this year. In 2022, the company reported Scope 1 emissions of 404,000 kg CO2e and Scope 2 emissions of 282,600 kg CO2e, resulting in a combined total of 686,600 kg CO2e for these two scopes. Natus Medical has set an ambitious target to reduce its carbon emissions to 22,000 metric tons CO2e by 2028, which represents a reduction of approximately 12.5% from its current levels. This commitment aligns with the Science Based Targets initiative (SBTi) and reflects the company's dedication to addressing climate change. As of now, there are no cascaded emissions data from a parent or related organization, indicating that Natus Medical's emissions data is independently reported. The company continues to focus on its climate commitments and reduction initiatives as part of its environmental sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 533,000,000 | 000,000 | - |
| Scope 2 | - | 000,000 | - |
| Scope 3 | - | - | - |
How Carbon Intensive is Natus Medical Incorporated's Industry?
How Carbon Intensive is Natus Medical Incorporated's Location?
Natus Medical Incorporated's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Natus Medical Incorporated has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boston Scientific
Thermo Fisher Scientific
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.